Skip to main content

Thalassemia clinical trials at UC Irvine

1 in progress, 0 open to eligible people

Showing trials for
  • Etavopivat in Patients With Thalassemia or Sickle Cell Disease

    Sorry, in progress, not accepting new patients

    This clinical trial is a Phase 2 study that will evaluate the safety and clinical activity of etavopivat in patients with thalassemia or sickle cell disease and test how well etavopivat works to lower the number of red blood cell transfusions required and increase hemoglobin.

    Orange, California and other locations

Last updated: